SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001655759-22-000015
Filing Date
2022-05-05
Accepted
2022-05-05 16:16:39
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20220505.htm   iXBRL 8-K 35583
2 EX-99 - EARNINGS RELEASE arvn-20220505xexx991.htm EX-99 82755
6 image_0a.jpg GRAPHIC 32844
  Complete submission text file 0001655759-22-000015.txt   314810

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20220505.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20220505_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20220505_pre.xml EX-101.PRE 13044
8 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20220505_htm.xml XML 11886
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 22896503
SIC: 2834 Pharmaceutical Preparations